Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Director/PDMR Shareholding

31 Oct 2025 10:33

RNS Number : 7102F
Severfield PLC
31 October 2025
 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Sanderson

2

Reason for the notification

a)

Position/status

Company Secretary

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Performance Share Plan as a conditional award of shares. Subject to performance conditions and continued service, the award normally vests in June 2028.

The performance conditions are weighted as follows:

· 50% is based on an EPS target for the year ending 31 March 2028 of 5.8 pence (threshold performance - 12.5% vests) to 7.9 pence (maximum performance - 50% vests) with linear interpolation in between. This represents a PBT range of £22m to £30m.

· 20% is based on an ROCE target for the year ending 31 March 2028 of 10% (threshold performance -5% vests) to 13% (maximum performance - 20% vests) with linear interpolation in between.

· 30% is based on 5 key transformational objectives relating to improved market prioritisation, manufacturing and project delivery. Certain details of the transformation programme metrics are commercially sensitive and will therefore be disclosed retrospectively at the point of vesting.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

269,737

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

30/10/25

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matt Gamble

2

Reason for the notification

a)

Position/status

Group financial controller

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Performance Share Plan as a conditional award of shares. Subject to performance conditions and continued service, the award normally vests in June 2028.

The performance conditions are weighted as follows:

· 50% is based on an EPS target for the year ending 31 March 2028 of 5.8 pence (threshold performance - 12.5% vests) to 7.9 pence (maximum performance - 50% vests) with linear interpolation in between. This represents a PBT range of £22m to £30m.

· 20% is based on an ROCE target for the year ending 31 March 2028 of 10% (threshold performance -5% vests) to 13% (maximum performance - 20% vests) with linear interpolation in between.

· 30% is based on 5 key transformational objectives relating to improved market prioritisation, manufacturing and project delivery. Certain details of the transformation programme metrics are commercially sensitive and will therefore be disclosed retrospectively at the point of vesting.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

114,474

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

30/10/25

f)

Place of the transaction

Outside a trading venue

 

Name of Company Official responsible for making notification: 

Mark Sanderson, Company Secretary

Contact details: 01845 577896

Severfield plc

Severs House

Dalton Airfield Industrial Estate

Thirsk

North Yorkshire

YO7 3JN

31st October 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMBBMTMTJJBMA
Date   Source Headline
2nd Jun 202612:08 pmRNSVoting Rights and Share Capital Update
31st Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSAppointment of Chief Financial Officer
29th Jan 20262:45 pmRNSStrategic Review of the Modular Solutions Business
2nd Dec 20257:00 amRNSInterim Results
1st Dec 20253:54 pmRNSTotal Voting Rights
31st Oct 202510:33 amRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSNotification of CEO Start Date & Notice of Results
3rd Oct 202510:16 amRNSHolding(s) in Company
23rd Sep 202511:11 amRNSAppointment of Interim Chief Financial Officer
11th Sep 20257:00 amRNSDirectorate Change
2nd Sep 20251:40 pmRNSResult of AGM
2nd Sep 20257:00 amRNSAGM trading update
13th Aug 20257:00 amRNSAppointment of Chief Executive Officer
29th Jul 20254:01 pmRNSDirector/PDMR Shareholding
29th Jul 202511:30 amRNSDirector/PDMR Shareholding
24th Jul 20257:43 amRNS-RProgressive publishes new research
24th Jul 20257:00 amRNSFinal Results
22nd Jul 20253:27 pmRNSHolding(s) in Company
18th Jul 20251:23 pmRNSJSW Severfield Structures Limited Option Agreement
7th Jul 20257:00 amRNSNotice of Results
4th Jun 20254:52 pmRNSTotal Voting Rights
22nd May 20257:00 amRNSHolding(s) in Company
25th Apr 20252:36 pmRNSDirector/PDMR Shareholding
24th Apr 20257:45 amRNS-RProgressive publishes new research
24th Apr 20257:00 amRNSPre-close trading update
1st Apr 20252:50 pmRNSBlock listing six monthly return
1st Apr 20252:06 pmRNSTotal Voting Rights
28th Mar 20258:15 amRNS-RProgressive publishes new research
26th Mar 20257:00 amRNSDirectorate Change
24th Mar 20259:36 amRNSChange in Director's Details Notification
3rd Mar 20257:01 amRNSShare Buyback Programme Cancellation
3rd Mar 20257:00 amRNSTrading Update
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20258:30 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20243:40 pmRNSHolding(s) in Company
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:20 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.